Stock Information
Amylyx Pharmaceuticals Inc (AMLX)
Ticker Symbol: AMLX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $3,791.45 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.43
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -52.92%
Latest News
-
Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
Tue, Oct 6, 2026 12:00 PM
-
Amylyx Pharma To Present Phase 3 Topline Data Highlighting Avexitide’s Efficacy And Safety At ObesityWeek 2026 Annual Meeting
Tue, Oct 6, 2026 8:07 AM
-
Amylyx Pharma Q2 2026 Earnings Call Transcript
Mon, Oct 5, 2026 7:25 AM
-
3 High Growth Stocks To Own In October 2026
Sun, Oct 4, 2026 5:07 PM
-
Amylyx Pharmaceuticals And 2 More Quality Growth Stocks
Sun, Oct 4, 2026 7:09 AM
Key Financials
Financial data not available
